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C hemistry has made tremendous advances over the past four decades in the broad fields ~f synthesis 
and understanding chemical reactivity. In that same time 
span, a series of revolutionary events occurred in biology. 
First came the discovery of the double helical structure of 
DNA in the 1950s by Watson and Crick. This discovery 
allowed the elucidation of the mechanisms of DNA 
replication-how DNA makes copies of itself-and DNA 
transcription and translation-the processes that allow 
the genetic code to be read and translated into proteins. 
In the 1970s, the techniques that permit DNA to be cut 
and spliced in controlled and well-defined ways were 
invented and the technology of recombinant DNA was 
born. 
Chemistry plays a pivotal role in this biological 
revolution because biological events involve molecules 
and molecular interactions. No scientists are better 
qualified to tackle the problem of determining the 
structure and the shape of molecules than chemists. Our 
society is entering an era in which chemists have the 
i opportunity to solve some of the most important prob-
lems in biology and biomedical science. 
Each strand of DNA consists of a linear polymer of 
nucleotides, which are phosphorylated versions of four 
different bases: adenine (A), guanine (G), cytosine (C), 
and thymidine (T). Physical chemical concepts readily 
explain what holds these nucleotides to complimentary 
nucleotides on the second strand of the DNA molecules. 
Hydrogen bonding dictates that the base adenine matches 
up with the base thymidine and the base guanine matches 
up with the base cytosine (see structures). These basic 
principles of chemistry make it possible for scientists to 
explain, in a very fundamental way, how life works. 
The quantity of DNA that encodes the entire human 
genome consists of about three billion such base pairs. 
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That is three billion chemical bits of information. These 
chromosomes-humans have 23 pairs-are the informa-
tion repository, or encyclopedia, for the construction of 
a human being. Molecular biologists estimate that there 
are 100,000 to 300,000 segments of information or 
genes contained on these 23 pairs of chromosomes. 
Each gene, typically, is the blueprint for one protein. 
The three-dimensional shape of proteins gives our bodies 
form and function and allows the proteins to carry out 
the complex chemistry of life. Clearly, then, understand-
ing the structure of human chromosomes and genes is 
one of the first steps toward understanding the funda-
mental machinery of human existence. We already under-
stand a great deal about those structures, but there is 
much more to learn. These are enormous molecules, and 
the subtle and complex interactions among them deter-
mine the difference, for example, between health and 
disease. 
During the past few years, there has been consider-
able discussion about whether scientists should begin the 
task of first mapping and then sequencing the human 
genome. This is a task of staggering dimensions. Physical 
mapping means using restriction endonucleases to cut up 
chromosomes and then determine the order of the 
resulting fragments. Genetic mapping, a somewhat less 
daunting task that already is being undertaken, means 
locating on chromosomes about 400 known genetic 
markers. Seq-uencing is the analysis of the order of each of 
the three billion base pairs that make up the human 
geno~e. 
Seq~ncing the Human Gen01ne 
First, researchers will have to separate the 23 human 
chromosomes and obtain a significant quantity of each 
one. Once the chromosomes have been sorted, one 
strategy that has been proposed is to break each chromo-
some into fragments, each fragment containing about 
40,000 base pairs. Each chromosome would yield about 
2500 of these fragments, and their order on the chromo-
somes would then have to be determined. These frag-
ments, in turn, would have to be broken down into 
fragments of a suitable size for direct sequencing, about 
1000 base pairs long. Each chromosome would yield 
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The potential applications 
of possessing the sequence 
of the entire human 
genome are enormous. 
about 100,000 such fragments. Simple arithmetic shows 
that, at a rate of about one million bases a day, sequenc-
ing the human genome will take 10 years to complete. 
The potential applications of possessing the 
sequence of the entire human genome are enormous. 
These applications include such things as the ability to 
gain a basic understanding of why certain individuals are 
susceptible to genetic disorders like cancer, heart disease, 
and mental illness. 
At Caltech, biology professor Leroy Hood and his 
co-workers have worked on developing the chemistry and 
instrumentation for sequencing DNA and proteins. 
Hood would be the first to acknowledge that current 
automated DNA sequencing is still a relatively immature 
technology and that it will require significant further 
development in both the underlying chemistry and the 
instrumentation before it is ready to take on the task of 
sequencing the human genome. That work is being done 
both at Caltech in Hood's group and more recently by a 
group at DuPont. The step toward sequencing the human 
.genome should be the automation of the entire sequenc-
ing procedure, not just the downstream portion of 
sequencing nucleotides, an effort that may take five to ten 
years. Within that time, nucleotide sequencing should 
have improved in speed by a factor of about 100 and 
improved significantly in accuracy. It should then be 
ready to be applied to the human genome. 
During the 15 to 20 years it will take to map and 
sequence the human encyclopedia, it is probable that tl1e 
fields of molecular biology and biological chemistry will 
make new strides into understanding the mechanisms that 
control gene expression. Gene expression is the product 
of an extensive array of interactions among DNA, RNA, 
and proteins. Chemists want to understand the physical 
and chemical principle~ that govern mis process. One 
aspect of this research will be to isolate and determine the 
strucrures of protein-DNA assemblies that regulate how 
genes are expressed. It is conceivable, therefore, that 
concurrent with the determination of the sequence of 
human DNA, the "software" of the human genome also 
will be understood, and synthetic chemists will be able to 
engineer at the molecular level novel synthetic materials 
that read unique DNA sequences. 
For instance, the natural restriction endonucleases 
that have been used so powerfully by molecular biologists 
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in recombinant DNA techniques can recognize a specific 
DNA sequence, four to eight base pairs in size, and cut 
the DNA molecule at that site. A consequence of a four-
letter alphabet for double ·helical DNA is that each 
binding site size yields a specific number of unique sites. 
There are, for example, 136 unique binding sites consist-
ing of four base pairs and 2080 unique sites consisting of 
six base pairs. In terms of physical mapping of the 
genome, this number of unique binding sites limits what 
might be called the resolution of the map. 
Natural restriction endonucleases recognize and bind to 
sequences in DNA from four to eight base pairs long and 
then cut the DNA at that site.· A question synthetic 
chemists in my laboratory have addressed is whether we 
can improve on the specificity of natural restriction 
endonucleases. In other words, is it possible to modify 
natural DNA-binding molecules or synthesize entirely 
new one that will recognize unique sequences of 12 to 15 
base pairs? Again, because DNA uses a four-letter 
alphabet, there are 10 million to 100 million such unique 
DNA sequences, and hence, one could potentially create 
that many molecules. To be specific at the level of one 
unique gene in large chromosomal DNA, molecules need 
to recognize DNA sequences made up of 15 base pairs. 
This is a chemistry problem in molecular recogni-
tion. Despite all the successes of chemistry in the past 
30-40 years, the field of molecular recognition in organic 
chemistry-how macromolecules fold and fit together-
is still in its infancy. The way to solve this problem is not 
by serendipity or by focusing on one particular sequence, 
but rather to work toward a general solution. That is, to 
elaborate a set of chemical principles that govern DNA 
recognition without trying to anticipate the direct appli-
cation of the DNA-binding molecule in each case. 
However, the eventual applications are important. 
Once scientists have in hand the physical map of the 
human genome, and for example, know where the gene 
that causes a particular genetic disease is located, the 
question is, What are they going to do about it? If the 
principles of gene expression and regulation are known, 
then most likely chemists will be able to build artificial 
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repressors for specific DNA sequences to control certain 
disease states. 
Because the understanding of the chemistry of 
molecular complexation is still primitive, the initial 
efforts in this research borr<?w heavily from nature. 
Numerous natural compounds bind to DNA. The restric-
tion endonucleases, as we have seen, bind and cleave 
DNA. A variety of small molecules, many of them drugs 
having antibiotic, antiviral, or antirumor activity, also 
bind to DNA and some also cleave it. Their pharmaco-
logical activity results, presumably, from their ability to 
interfere with some aspect of DN.Ns function or repair. 
The goal is to take such small molecules that bind DNA 
in a modest fashion and improve them to new and novel 
specificities. 
To screen a large number of potential binding sites 
on DNA, we couple the binding event to the analytical 
power of gel electrophoresis. This step is accomplished by 
attaching to the, DNA-binding molecule another moiety 
that cleaves DNA. Thus, we create molecules with two 
functions: the ability to bind to specific DNA sequences 
and then the ability to cut the DNA at points adjacent to 
that sequence. These bifunctional molecules form the 
basis of a technique called affinity cleaving1 that is, the 
binding event on DNA is converted to a sequencing 
event (see Figure 1 ). Identification of the preferred 
binding sites of our designed synthetic molecules is a first 
step toward addressing the underlying principles of 
recognition of DNA at the molecular level. 
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NaruraJ products we have investigated are netropsin 
and distamycin, di- and tripeptides that are known to 
bind in the minor groove of right-handed DNA rich in 
adenine and thymidine bases. The specific interactions 
involved in this binding process have been determined 
from the high-resolution crystal strucrures of a netrop-
sin- and clistamycin-oligonucleotide complexes (see Fig-
ure 2 ). The question is whether we can improve and aJter 
the specificity of this naruraJ product by building anaJogs 
of the molecule that would bind larger DNA fragments. 
One simple strategy is to build longer versions of the 
narural product. The longer versions are peptides that 
consist of four to nine amino acids designed after the 
strucrure of the tripeptide. These longer molecules based 
on distamycin do, in fact, possess a higher specificity for 
DNA approaching that of restriction endonucleases. So 
we are moving in the right direction. 
Molecular Engineering 
Figt-trc 2. Il JJo nctropsin analogs connected by n 
tctract/Jylenc glycol tether bind a 10 base-pair sequence 
in the presence of barium metal cation by forming 
hydrngen bonds (dotted li11es) mith lone pair clectrom 
o. The EDTA-Fc"grot""p is highlighted. 
Another generation of these synthetic molecules will be 
derived from our understanding of how proteins bind 
DNA. It might be possible to design synthetic hybrid 
protein molecules with two strucrural and functional 
domains, that is, create synthetic peptides derived from 
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two different proteins. Researchers in our group have 
combined 52 amino acids derived from the natural 
enzyme, Hin-recombinase, which contains 190 amino 
acids, with three amino acids that constitute the copper 
binding site in serum albumin. This hybrid synthetic 
protein possesses two separate ·structural and functional 
domains. The 52-amino acid fragment provides the DNA 
binding specificity of the Hin protein and the three-
amino acid fragment binds copper and provides oxidative 
cleavage of DNA in the presence of hydrogen peroxide 
and ascorbate. 
We have also constructed oligonucleotides to which 
is attached an EDTA-iron DNA-cleaving function. We 
have shown that certain such oligonucleotides ( 15 bases 
long) will form a triple helix in the major groove of 
double helical DNA (Figure 3) 11 to 15 base pairs long. 
This finding makes possible a general solution to the 
problem of sequence-specific DNA recognition. Within 
certain constraints, we can novy build molecules that can 
recognize unique specific stretches of DNA 15 base pairs 
long, which is the level of specificity we need to 
recognize individual genes in the human genome. 
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Figure 3. Oligonucleotide recognizes 15-base-pair 
sequence in 4000-base-pair DNA fragment by 
forming a triple helix 11Jith double-stranded DNA. 
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Catal51tic Antibodi-es 
Turning from the problem of sequence-specific DNA 
recognition, let me focus briefly on protein recognition 
and monoclonal antibodies, another important leg of 
biotechnology. Antibodies are the protein molecules 
produced by an organism's immune system that bind to 
foreign molecules in the body and tag them as foreign so 
that they can be eliminated. In immunological terms, the 
foreign molecule is an antigen. In an intact organism, a 
range of subtly different antibodies can be generated for 
any given antigen; there are, in other words, a number of 
ways to solve the problem of binding a given antigen. 
This condition is called a polyclonal response. Antibody-
producing B lymphocytes can be fused with a cultured 
myeloma cell to produce a hybridoma that secretes a 
specific monoclonal antibody (1). 
Recently, independent research performed at 
the Research Institute of Scripps Clinic (2) and at 
the University of California, Berkeley (3), shows that, 
through careful design of an antigen, one can produce an 
antibody that catalyzes a chemical reaction. Schultz at 
Berkeley and Lerner and Tramontano at Scripps pro-
duced antibodies that catalyze, with a high degree of 
specificity, hydrolysis of esters and carbonates. The 
antigenic molecules used to elicit these antibodies are 
phosphonates, and they mimic the transition state of this 
hydrolysis reaction. 
These researchers are exploring ways to adapt this 
idea to devise molecules that will cleave protein molecules 
with great specificity. One direction the researchers are 
pursuing to introduce catalytic activity into antibodies is 
production of what might be called semisynthetic catalytic 
antibodies. The idea is to produce an antibody that binds 
a specific molecule, and chemically to attach catalytic 
groups such as a metal ion to the antibody to carry out 
a reaction such as hydrolysis of the peptide bond that 
links amino acids together in a protein. In such a 
molecule, the antibody provides the binding specificity 
and synthetic catalyst proVides the needed chemistry. 
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The Future 
In short, when the chemical composition of the hardware 
and software of the human cell is described at the 
molecular level, the potential will exist to synthesize 
molecules to control disease in .,a very precise way. Over 
the next 20 years, chemists will participate with biologists 
in solving these extremely important and challenging 
problems. The solutions will have tremendous practical 
implications for humanity. 
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